Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Collagen VII Gene Therapy on Squamous Cell Carcinoma Recurrence in Recessive Dystrophic Epidermolysis Bullosa Skin

NCT06731933 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT06731933
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06731933 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Collagen VII Gene Therapy on Squamous Cell Carcinoma Recurrence in Recessive Dystrophic Epidermolysis Bullosa Skin
Lead sponsor
Stanford University
Phase
Phase 2
Overall status
Recruiting
Start date
March 28, 2025
Completion date
February 28, 2027
Enrollment
16 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

squamous cell carcinoma